Literature DB >> 15773280

Calcium pectinate capsules for colon-specific drug delivery.

Chen Xu1, Jun Shou Zhang, Yun Mo, Ren Xiang Tan.   

Abstract

The calcium pectinate (CaP) capsule, a novel, colon-specific delivery system, was designed and developed using 5-fluorouracil (5-FU) as a model drug. Technically, CaP capsules were prepared by dipping a glass or stainless steel rod successively into pectin and calcium chloride solutions, followed by subsequent air-drying and coating. In vitro studies showed that the release of 5-FU from CaP capsules markedly increased in the presence of rat cecal contents, and the release characteristic was mainly associated with some capsule parameters such as calcium content, shell thickness, and coat amount. Gamma scintigraphic studies demonstrated that CaP capsules could pass through the stomach and small intestine intact and could release drug in colon. The 5-FU releasing characteristics acquired both from in vitro biomimic dissolution experiments and from healthy volunteers indicated that the newly developed CaP capsule possessed the ideal colon-specific drug delivery characteristic.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773280     DOI: 10.1081/ddc-200046990

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  3 in total

1.  Polymeric Nano-Micelles as Novel Cargo-Carriers for LY2157299 Liver Cancer Cells Delivery.

Authors:  Nemany Abdelhamid Nemany Hanafy; Alessandra Quarta; Marzia Maria Ferraro; Luciana Dini; Concetta Nobile; Maria Luisa De Giorgi; Sonia Carallo; Cinzia Citti; Antonio Gaballo; Giuseppe Cannazza; Rosaria Rinaldi; Gianluigi Giannelli; Stefano Leporatti
Journal:  Int J Mol Sci       Date:  2018-03-06       Impact factor: 5.923

2.  Influence of In Situ Calcium Pectinate Coating on Metoprolol Tartrate Pellets for Controlled Release and Colon-Specific Drug Delivery.

Authors:  Pimphaka Wanasawas; Ampol Mitrevej; Nuttanan Sinchaipanid
Journal:  Pharmaceutics       Date:  2022-05-15       Impact factor: 6.525

Review 3.  Anti-cancer activities of pH- or heat-modified pectin.

Authors:  Lionel Leclere; Pierre Van Cutsem; Carine Michiels
Journal:  Front Pharmacol       Date:  2013-10-08       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.